Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SOLESENCE, INC.SLSN · Entity 7041 | Director | December 24, 2025 | December 30, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SOLESENCE, INC.
Report date December 24, 2025 · Filed December 30, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,085,698 |
Reported balance
After 2025-12-24 transaction · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · 2025-12-24 · Purchase · Acquired 1,500 · Balance 2,085,698 |
| Common StockSEC Table I · non-derivative | Direct | 2,086,698 |
Reported balance
After 2025-12-24 transaction · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · 2025-12-24 · Purchase · Acquired 1,000 · Balance 2,086,698 |
| Common StockSEC Table I · non-derivative | Direct | 2,084,198 |
Reported balance
Holding disclosure · report date 2025-12-24 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 2,084,198 |
| Deferred Common StockSEC Table II · derivative / convertible security | Direct | 20,030 |
Reported balance
Holding disclosure · report date 2025-12-24 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 20,030 F1: Each share of deferred common stock represents the right to receive one share of common stock. F2: The deferred common stock becomes payable upon the reporting person's termination of service as a director of the Company. F3: Pursuant to such plan, the reporting person elected to defer receipt of such shares and receive a cumulative total of 20,030 shares of deferred common stock which will all be accounted for under the Company's Non-Employee Director Deferred Compensaion Plan. |
| Common Stock (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $1.85 · Expires 2026-11-17 | Direct | 2,000 |
Reported balance
Holding disclosure · report date 2025-12-24 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 2,000 F4: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued at identical exercise prices to the conversion prices of the respective stock appreciation rights. These 2000 shares were issued with an exercise price of $1.85. |
| Common Stock (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $4.17 · Expires 2028-12-28 | Direct | 20,000 |
Reported balance
Holding disclosure · report date 2025-12-24 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 20,000 F5: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments. |
| Common Stock (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $1.17 · Expires 2029-12-20 | Direct | 13,334 |
Reported balance
Holding disclosure · report date 2025-12-24 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 13,334 F5: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments. |
| Common Stock (right to purchase)SEC Table II · derivative / convertible security · Conversion / exercise price $0.61 · Expires 2030-12-27 | Direct | 12,600 |
Reported balance
Holding disclosure · report date 2025-12-24 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 12,600 F5: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments. |
| Common Stock (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.44 · Expires 2031-12-31 | Direct | 12,000 |
Reported balance
Holding disclosure · report date 2025-12-24 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 12,000 F5: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments. |
Filing footnotes · ownership attribution and instrument terms
F1: Each share of deferred common stock represents the right to receive one share of common stock.
F2: The deferred common stock becomes payable upon the reporting person's termination of service as a director of the Company.
F3: Pursuant to such plan, the reporting person elected to defer receipt of such shares and receive a cumulative total of 20,030 shares of deferred common stock which will all be accounted for under the Company's Non-Employee Director Deferred Compensaion Plan.
F4: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued at identical exercise prices to the conversion prices of the respective stock appreciation rights. These 2000 shares were issued with an exercise price of $1.85.
F5: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 25, 2017 Filed Aug 28, 2017 13:07 UTC | SOLESENCE, INC. NANX · Entity 7041 | PurchaseCommon Stock | 3,150 | $0.67 | $2,110.50 |
DisclosureSEC source: 0001209191-17-050354 · doc4.xml · nonDerivative · entry 4 WHITMORE R JANET · CIK 0001173970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,160,172 Read SEC document |
| August 25, 2017 Filed Aug 28, 2017 13:07 UTC | SOLESENCE, INC. NANX · Entity 7041 | PurchaseCommon Stock | 5,750 | $0.67 | $3,823.75 |
DisclosureSEC source: 0001209191-17-050354 · doc4.xml · nonDerivative · entry 3 WHITMORE R JANET · CIK 0001173970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,157,022 Read SEC document |
| August 02, 2017 Filed Aug 4, 2017 17:09 UTC | SOLESENCE, INC. NANX · Entity 7041 | PurchaseCommon Stock | 5,000 | $0.67 | $3,350.00 |
DisclosureSEC source: 0001209191-17-047649 · doc4.xml · nonDerivative · entry 3 WHITMORE R JANET · CIK 0001173970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,151,272 Read SEC document |
| June 21, 2017 Filed Jun 21, 2017 21:01 UTC | SOLESENCE, INC. NANX · Entity 7041 | PurchaseCommon Stock | 5,000 | $0.67 | $3,350.00 |
DisclosureSEC source: 0001209191-17-041216 · doc4.xml · nonDerivative · entry 4 WHITMORE R JANET · CIK 0001173970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,146,272 Read SEC document |
| June 21, 2017 Filed Jun 21, 2017 21:01 UTC | SOLESENCE, INC. NANX · Entity 7041 | PurchaseCommon Stock | 2,500 | $0.67 | $1,662.50 |
DisclosureSEC source: 0001209191-17-041216 · doc4.xml · nonDerivative · entry 3 WHITMORE R JANET · CIK 0001173970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,141,272 Read SEC document |
| June 20, 2017 Filed Jun 21, 2017 12:35 UTC | SOLESENCE, INC. NANX · Entity 7041 | PurchaseCommon Stock | 2,000 | $0.66 | $1,320.00 |
DisclosureSEC source: 0001209191-17-041154 · doc4.xml · nonDerivative · entry 4 WHITMORE R JANET · CIK 0001173970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,138,772 Read SEC document |
| June 20, 2017 Filed Jun 21, 2017 12:35 UTC | SOLESENCE, INC. NANX · Entity 7041 | PurchaseCommon Stock | 1,250 | $0.66 | $818.75 |
DisclosureSEC source: 0001209191-17-041154 · doc4.xml · nonDerivative · entry 3 WHITMORE R JANET · CIK 0001173970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,136,772 Read SEC document |
| June 16, 2017 Filed Jun 19, 2017 12:24 UTC | SOLESENCE, INC. NANX · Entity 7041 | PurchaseCommon Stock | 3,657 | $0.67 | $2,434.10 |
DisclosureSEC source: 0001209191-17-040713 · doc4.xml · nonDerivative · entry 3 WHITMORE R JANET · CIK 0001173970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,135,522 Read SEC document |
| June 13, 2017 Filed Jun 14, 2017 12:32 UTC | SOLESENCE, INC. NANX · Entity 7041 | PurchaseCommon Stock | 16,000 | $0.66 | $10,560.00 |
DisclosureSEC source: 0001209191-17-039741 · doc4.xml · nonDerivative · entry 3 WHITMORE R JANET · CIK 0001173970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,131,865 Read SEC document |
| June 09, 2017 Filed Jun 12, 2017 16:41 UTC | SOLESENCE, INC. NANX · Entity 7041 | PurchaseCommon Stock | 3,750 | $0.66 | $2,475.00 |
DisclosureSEC source: 0001209191-17-039051 · doc4.xml · nonDerivative · entry 6 WHITMORE R JANET · CIK 0001173970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,115,865 Read SEC document |
| June 09, 2017 Filed Jun 12, 2017 16:41 UTC | SOLESENCE, INC. NANX · Entity 7041 | PurchaseCommon Stock | 1,150 | $0.65 | $747.50 |
DisclosureSEC source: 0001209191-17-039051 · doc4.xml · nonDerivative · entry 5 WHITMORE R JANET · CIK 0001173970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,112,115 Read SEC document |
| June 08, 2017 Filed Jun 12, 2017 16:41 UTC | SOLESENCE, INC. NANX · Entity 7041 | PurchaseCommon Stock | 3,750 | $0.65 | $2,441.25 |
DisclosureSEC source: 0001209191-17-039051 · doc4.xml · nonDerivative · entry 4 WHITMORE R JANET · CIK 0001173970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,110,965 Read SEC document |
| June 08, 2017 Filed Jun 12, 2017 16:41 UTC | SOLESENCE, INC. NANX · Entity 7041 | PurchaseCommon Stock | 1,250 | $0.67 | $831.88 |
DisclosureSEC source: 0001209191-17-039051 · doc4.xml · nonDerivative · entry 3 WHITMORE R JANET · CIK 0001173970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,107,215 Read SEC document |
| February 21, 2017 Filed Feb 22, 2017 22:46 UTC | SOLESENCE, INC. NANX · Entity 7041 | GrantStock Option (right to buy) · Derivative | 10,000 | $0.68 Strike: $0.68 | $6,800.00 |
DisclosureSEC source: 0001209191-17-013458 · doc4.xml · derivative · entry 18 WHITMORE R JANET · CIK 0001173970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2027-02-21 F6 · derivative.exercise_price: Beginning on this date, subject to certain restrictions, the stock option vests in three equal annual installments. Read SEC document |
| February 21, 2017 Filed Feb 22, 2017 22:46 UTC | SOLESENCE, INC. NANX · Entity 7041 | GiftCommon Stock | 102,909 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-013458 · doc4.xml · nonDerivative · entry 2 WHITMORE R JANET · CIK 0001173970 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Son Disclosed balance after: 102,909 F1 · price: Represents inheritance from the estate of a non-reporting person Read SEC document |
| February 21, 2017 Filed Feb 22, 2017 22:46 UTC | SOLESENCE, INC. NANX · Entity 7041 | GiftCommon Stock | 102,909 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-17-013458 · doc4.xml · nonDerivative · entry 1 WHITMORE R JANET · CIK 0001173970 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Daughter Disclosed balance after: 135,584 F1 · price: Represents inheritance from the estate of a non-reporting person Read SEC document |
| December 02, 2016 Filed Dec 2, 2016 21:30 UTC | SOLESENCE, INC. NANX · Entity 7041 | PurchaseCommon Stock | 6,000 | $0.72 | $4,320.00 |
DisclosureSEC source: 0001209191-16-153030 · doc4.xml · nonDerivative · entry 2 WHITMORE R JANET · CIK 0001173970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,105,965 Read SEC document |
| November 23, 2016 Filed Nov 28, 2016 14:30 UTC | SOLESENCE, INC. NANX · Entity 7041 | PurchaseCommon Stock | 7,500 | $0.71 | $5,325.00 |
DisclosureSEC source: 0001209191-16-152063 · doc4.xml · nonDerivative · entry 2 WHITMORE R JANET · CIK 0001173970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,099,965 Read SEC document |
| November 17, 2016 Filed Nov 21, 2016 17:01 UTC | SOLESENCE, INC. NANX · Entity 7041 | PurchaseCommon Stock | 11,300 | $0.72 | $8,136.00 |
DisclosureSEC source: 0001209191-16-151357 · doc4.xml · nonDerivative · entry 2 WHITMORE R JANET · CIK 0001173970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,092,465 Read SEC document |
| November 17, 2016 Filed Nov 21, 2016 15:33 UTC | SOLESENCE, INC. NANX · Entity 7041 | GrantStock Option (right to buy) · Derivative | 2,000 | $0.99 Strike: $0.99 | $1,980.00 |
DisclosureSEC source: 0001209191-16-151355 · doc4.xml · derivative · entry 17 WHITMORE R JANET · CIK 0001173970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2026-11-17 F7 · derivative.exercise_price: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued at identical exercise prices to the conversion prices of the respective stock appreciation rights. 2,000 were issued with an exercise price of $0.90, 2,000 were issued with an exercise price of $1.05, 2,000 were issued with an exercise price of $1.18, 2,000 were issued with an exercise price of $0.84, 2,000 were issued with an exercise price of $1.85, 2,000 were issued with an exercise price of $1.10, and 2,000 were issued with an exercise price of $0.99. F7 · price: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued at identical exercise prices to the conversion prices of the respective stock appreciation rights. 2,000 were issued with an exercise price of $0.90, 2,000 were issued with an exercise price of $1.05, 2,000 were issued with an exercise price of $1.18, 2,000 were issued with an exercise price of $0.84, 2,000 were issued with an exercise price of $1.85, 2,000 were issued with an exercise price of $1.10, and 2,000 were issued with an exercise price of $0.99. Read SEC document |
| November 17, 2016 Filed Nov 21, 2016 15:33 UTC | SOLESENCE, INC. NANX · Entity 7041 | GrantStock Option (right to buy) · Derivative | 2,000 | $1.10 Strike: $1.10 | $2,200.00 |
DisclosureSEC source: 0001209191-16-151355 · doc4.xml · derivative · entry 16 WHITMORE R JANET · CIK 0001173970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2026-11-17 F7 · derivative.exercise_price: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued at identical exercise prices to the conversion prices of the respective stock appreciation rights. 2,000 were issued with an exercise price of $0.90, 2,000 were issued with an exercise price of $1.05, 2,000 were issued with an exercise price of $1.18, 2,000 were issued with an exercise price of $0.84, 2,000 were issued with an exercise price of $1.85, 2,000 were issued with an exercise price of $1.10, and 2,000 were issued with an exercise price of $0.99. F7 · price: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued at identical exercise prices to the conversion prices of the respective stock appreciation rights. 2,000 were issued with an exercise price of $0.90, 2,000 were issued with an exercise price of $1.05, 2,000 were issued with an exercise price of $1.18, 2,000 were issued with an exercise price of $0.84, 2,000 were issued with an exercise price of $1.85, 2,000 were issued with an exercise price of $1.10, and 2,000 were issued with an exercise price of $0.99. Read SEC document |
| November 17, 2016 Filed Nov 21, 2016 15:33 UTC | SOLESENCE, INC. NANX · Entity 7041 | GrantStock Option (right to buy) · Derivative | 2,000 | $1.85 Strike: $1.85 | $3,700.00 |
DisclosureSEC source: 0001209191-16-151355 · doc4.xml · derivative · entry 15 WHITMORE R JANET · CIK 0001173970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2026-11-17 F7 · derivative.exercise_price: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued at identical exercise prices to the conversion prices of the respective stock appreciation rights. 2,000 were issued with an exercise price of $0.90, 2,000 were issued with an exercise price of $1.05, 2,000 were issued with an exercise price of $1.18, 2,000 were issued with an exercise price of $0.84, 2,000 were issued with an exercise price of $1.85, 2,000 were issued with an exercise price of $1.10, and 2,000 were issued with an exercise price of $0.99. F7 · price: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued at identical exercise prices to the conversion prices of the respective stock appreciation rights. 2,000 were issued with an exercise price of $0.90, 2,000 were issued with an exercise price of $1.05, 2,000 were issued with an exercise price of $1.18, 2,000 were issued with an exercise price of $0.84, 2,000 were issued with an exercise price of $1.85, 2,000 were issued with an exercise price of $1.10, and 2,000 were issued with an exercise price of $0.99. Read SEC document |
| November 17, 2016 Filed Nov 21, 2016 15:33 UTC | SOLESENCE, INC. NANX · Entity 7041 | GrantStock Option (right to buy) · Derivative | 2,000 | $0.84 Strike: $0.84 | $1,680.00 |
DisclosureSEC source: 0001209191-16-151355 · doc4.xml · derivative · entry 14 WHITMORE R JANET · CIK 0001173970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2026-11-17 F7 · derivative.exercise_price: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued at identical exercise prices to the conversion prices of the respective stock appreciation rights. 2,000 were issued with an exercise price of $0.90, 2,000 were issued with an exercise price of $1.05, 2,000 were issued with an exercise price of $1.18, 2,000 were issued with an exercise price of $0.84, 2,000 were issued with an exercise price of $1.85, 2,000 were issued with an exercise price of $1.10, and 2,000 were issued with an exercise price of $0.99. F7 · price: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued at identical exercise prices to the conversion prices of the respective stock appreciation rights. 2,000 were issued with an exercise price of $0.90, 2,000 were issued with an exercise price of $1.05, 2,000 were issued with an exercise price of $1.18, 2,000 were issued with an exercise price of $0.84, 2,000 were issued with an exercise price of $1.85, 2,000 were issued with an exercise price of $1.10, and 2,000 were issued with an exercise price of $0.99. Read SEC document |
| November 17, 2016 Filed Nov 21, 2016 15:33 UTC | SOLESENCE, INC. NANX · Entity 7041 | GrantStock Option (right to buy) · Derivative | 2,000 | $1.18 Strike: $1.18 | $2,360.00 |
DisclosureSEC source: 0001209191-16-151355 · doc4.xml · derivative · entry 13 WHITMORE R JANET · CIK 0001173970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2026-11-17 F7 · derivative.exercise_price: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued at identical exercise prices to the conversion prices of the respective stock appreciation rights. 2,000 were issued with an exercise price of $0.90, 2,000 were issued with an exercise price of $1.05, 2,000 were issued with an exercise price of $1.18, 2,000 were issued with an exercise price of $0.84, 2,000 were issued with an exercise price of $1.85, 2,000 were issued with an exercise price of $1.10, and 2,000 were issued with an exercise price of $0.99. F7 · price: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued at identical exercise prices to the conversion prices of the respective stock appreciation rights. 2,000 were issued with an exercise price of $0.90, 2,000 were issued with an exercise price of $1.05, 2,000 were issued with an exercise price of $1.18, 2,000 were issued with an exercise price of $0.84, 2,000 were issued with an exercise price of $1.85, 2,000 were issued with an exercise price of $1.10, and 2,000 were issued with an exercise price of $0.99. Read SEC document |
| November 17, 2016 Filed Nov 21, 2016 15:33 UTC | SOLESENCE, INC. NANX · Entity 7041 | GrantStock Option (right to buy) · Derivative | 2,000 | $1.05 Strike: $1.05 | $2,100.00 |
DisclosureSEC source: 0001209191-16-151355 · doc4.xml · derivative · entry 12 WHITMORE R JANET · CIK 0001173970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2026-11-17 F7 · derivative.exercise_price: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued at identical exercise prices to the conversion prices of the respective stock appreciation rights. 2,000 were issued with an exercise price of $0.90, 2,000 were issued with an exercise price of $1.05, 2,000 were issued with an exercise price of $1.18, 2,000 were issued with an exercise price of $0.84, 2,000 were issued with an exercise price of $1.85, 2,000 were issued with an exercise price of $1.10, and 2,000 were issued with an exercise price of $0.99. F7 · price: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued at identical exercise prices to the conversion prices of the respective stock appreciation rights. 2,000 were issued with an exercise price of $0.90, 2,000 were issued with an exercise price of $1.05, 2,000 were issued with an exercise price of $1.18, 2,000 were issued with an exercise price of $0.84, 2,000 were issued with an exercise price of $1.85, 2,000 were issued with an exercise price of $1.10, and 2,000 were issued with an exercise price of $0.99. Read SEC document |
| November 17, 2016 Filed Nov 21, 2016 15:33 UTC | SOLESENCE, INC. NANX · Entity 7041 | GrantStock Option (right to buy) · Derivative | 2,000 | $0.90 Strike: $0.90 | $1,800.00 |
DisclosureSEC source: 0001209191-16-151355 · doc4.xml · derivative · entry 11 WHITMORE R JANET · CIK 0001173970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2026-11-17 F7 · derivative.exercise_price: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued at identical exercise prices to the conversion prices of the respective stock appreciation rights. 2,000 were issued with an exercise price of $0.90, 2,000 were issued with an exercise price of $1.05, 2,000 were issued with an exercise price of $1.18, 2,000 were issued with an exercise price of $0.84, 2,000 were issued with an exercise price of $1.85, 2,000 were issued with an exercise price of $1.10, and 2,000 were issued with an exercise price of $0.99. F7 · price: The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued at identical exercise prices to the conversion prices of the respective stock appreciation rights. 2,000 were issued with an exercise price of $0.90, 2,000 were issued with an exercise price of $1.05, 2,000 were issued with an exercise price of $1.18, 2,000 were issued with an exercise price of $0.84, 2,000 were issued with an exercise price of $1.85, 2,000 were issued with an exercise price of $1.10, and 2,000 were issued with an exercise price of $0.99. Read SEC document |
| November 17, 2016 Filed Nov 21, 2016 15:33 UTC | SOLESENCE, INC. NANX · Entity 7041 | Disposition to issuerStock Appreciation Right · Derivative | 14,000 | $1.18 Strike: $1.18 | $16,520.00 |
DisclosureSEC source: 0001209191-16-151355 · doc4.xml · derivative · entry 5 WHITMORE R JANET · CIK 0001173970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,000 shares Expires not disclosed F5 · security: The stock appreciation rights that were to become payable upon the reporting person's termination of service as a director of the Company. 2,000 were issued 4/8/2009 at a conversion price of $0.90, 2,000 were issued 7/1/2009 at a conversion price of $1.05, 2,000 were issued 10/1/2009 at a conversion price of $1.18, 2,000 were issued 1/4/2010 at a conversion price of $0.84, 2,000 were issued 4/1/2010 at a conversion price of $1.85, 2,000 were issued 7/1/2010 at a conversion price of $1.10, and 2,000 were issued 10/1/2010 at a conversion price of $0.99. F5 · derivative.exercise_date: The stock appreciation rights that were to become payable upon the reporting person's termination of service as a director of the Company. 2,000 were issued 4/8/2009 at a conversion price of $0.90, 2,000 were issued 7/1/2009 at a conversion price of $1.05, 2,000 were issued 10/1/2009 at a conversion price of $1.18, 2,000 were issued 1/4/2010 at a conversion price of $0.84, 2,000 were issued 4/1/2010 at a conversion price of $1.85, 2,000 were issued 7/1/2010 at a conversion price of $1.10, and 2,000 were issued 10/1/2010 at a conversion price of $0.99. F5 · derivative.expiration_date: The stock appreciation rights that were to become payable upon the reporting person's termination of service as a director of the Company. 2,000 were issued 4/8/2009 at a conversion price of $0.90, 2,000 were issued 7/1/2009 at a conversion price of $1.05, 2,000 were issued 10/1/2009 at a conversion price of $1.18, 2,000 were issued 1/4/2010 at a conversion price of $0.84, 2,000 were issued 4/1/2010 at a conversion price of $1.85, 2,000 were issued 7/1/2010 at a conversion price of $1.10, and 2,000 were issued 10/1/2010 at a conversion price of $0.99. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.